Nantong Jinghua Pharmaceutical Co Ltd (002349) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Based on the latest financial reports, Nantong Jinghua Pharmaceutical Co Ltd (002349) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥97.93 Million ≈ $14.33 Million USD) by net assets (CN¥3.09 Billion ≈ $452.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002349 net asset quality score to measure how much of total assets are equity-financed.

Nantong Jinghua Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Nantong Jinghua Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Nantong Jinghua Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Nantong Jinghua Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nantong Jinghua Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
engcon AB Cl B ST:ENGCON-B	0.079x
Zenner Metering Technology (Shanghai) Ltd. A SHE:301303	N/A
Dan Hotels TA:DANH	0.036x
Cablevision Holding SA BA:CVH	0.093x
Warom Technology Inc Co SHG:603855	-0.016x
Allis Electric Co Ltd TW:1514	-0.040x
JC Finance & Tax Interconnect Holdings Ltd SHE:002530	0.030x
Cello World Limited NSE:CELLO	0.010x

Annual Cash Flow Conversion Efficiency for Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Nantong Jinghua Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.15 Billion ≈ $460.83 Million	CN¥340.87 Million ≈ $49.88 Million	0.108x	+2.91%
2024-12-31	CN¥2.96 Billion ≈ $432.72 Million	CN¥311.02 Million ≈ $45.51 Million	0.105x	+1.25%
2023-12-31	CN¥2.80 Billion ≈ $410.35 Million	CN¥291.31 Million ≈ $42.63 Million	0.104x	-23.95%
2022-12-31	CN¥2.62 Billion ≈ $383.94 Million	CN¥358.39 Million ≈ $52.44 Million	0.137x	+14.86%
2021-12-31	CN¥2.57 Billion ≈ $376.01 Million	CN¥305.57 Million ≈ $44.71 Million	0.119x	-9.90%
2020-12-31	CN¥2.49 Billion ≈ $363.89 Million	CN¥328.22 Million ≈ $48.03 Million	0.132x	-0.67%
2019-12-31	CN¥2.15 Billion ≈ $314.28 Million	CN¥285.38 Million ≈ $41.76 Million	0.133x	+329.14%
2018-12-31	CN¥2.69 Billion ≈ $394.28 Million	CN¥83.43 Million ≈ $12.21 Million	0.031x	+7.96%
2017-12-31	CN¥2.65 Billion ≈ $387.36 Million	CN¥75.92 Million ≈ $11.11 Million	0.029x	-80.79%
2016-12-31	CN¥2.30 Billion ≈ $336.95 Million	CN¥343.80 Million ≈ $50.31 Million	0.149x	+538.78%
2015-12-31	CN¥2.23 Billion ≈ $326.88 Million	CN¥-76.01 Million ≈ $-11.12 Million	-0.034x	-214.26%
2014-12-31	CN¥1.53 Billion ≈ $224.56 Million	CN¥45.70 Million ≈ $6.69 Million	0.030x	+140.21%
2013-12-31	CN¥741.83 Million ≈ $108.55 Million	CN¥-54.94 Million ≈ $-8.04 Million	-0.074x	-168.54%
2012-12-31	CN¥714.87 Million ≈ $104.61 Million	CN¥77.25 Million ≈ $11.30 Million	0.108x	+65.90%
2011-12-31	CN¥636.30 Million ≈ $93.11 Million	CN¥41.45 Million ≈ $6.06 Million	0.065x	-13.63%
2010-12-31	CN¥544.45 Million ≈ $79.67 Million	CN¥41.06 Million ≈ $6.01 Million	0.075x	-82.10%
2009-12-31	CN¥137.11 Million ≈ $20.06 Million	CN¥57.76 Million ≈ $8.45 Million	0.421x	+191.81%
2008-12-31	CN¥118.66 Million ≈ $17.36 Million	CN¥17.13 Million ≈ $2.51 Million	0.144x	-60.84%
2007-12-31	CN¥91.86 Million ≈ $13.44 Million	CN¥33.86 Million ≈ $4.96 Million	0.369x	+16.34%
2006-12-31	CN¥70.00 Million ≈ $10.24 Million	CN¥22.18 Million ≈ $3.25 Million	0.317x	--

About Nantong Jinghua Pharmaceutical Co Ltd

SHE:002349 China Drug Manufacturers - Specialty & Generic

Market Cap

$825.80 Million

CN¥5.64 Billion CNY

Market Cap Rank

#9645 Global

#2437 in China

Share Price

CN¥6.79

Change (1 day)

+0.74%

52-Week Range

CN¥6.08 - CN¥8.28

All Time High

CN¥25.53